82 related articles for article (PubMed ID: 19150524)
21. High-resolution melting analysis of HPV-16L1 gene methylation: A promising method for prognosing cervical cancer.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Li X
Clin Biochem; 2015 Sep; 48(13-14):855-9. PubMed ID: 25982893
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.
Verlaat W; Snijders PJF; Novianti PW; Wilting SM; De Strooper LMA; Trooskens G; Vandersmissen J; Van Criekinge W; Wisman GBA; Meijer CJLM; Heideman DAM; Steenbergen RDM
Clin Cancer Res; 2017 Jul; 23(14):3813-3822. PubMed ID: 28119363
[No Abstract] [Full Text] [Related]
24. [Abnormal methylation of tumor growth suppressor genes as a potential marker of precancer of the cervix uteri].
Kekeeva TV; Zhevlova AI; Podistov IuI; Solov'eva IuV; Zaletaev DV; Nemtsova MV
Klin Lab Diagn; 2006 Mar; (3):46-9. PubMed ID: 16749492
[No Abstract] [Full Text] [Related]
25. Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens.
Kim GE; Kweon SS; Lee JS; Lee JH; Nam JH; Choi C
Anal Quant Cytopathol Histpathol; 2012 Aug; 34(4):195-203. PubMed ID: 23016466
[TBL] [Abstract][Full Text] [Related]
26. CpG island methylator phenotype in cancer.
Issa JP
Nat Rev Cancer; 2004 Dec; 4(12):988-93. PubMed ID: 15573120
[TBL] [Abstract][Full Text] [Related]
27. Cervical adenocarcinoma identification by testing for chromosomal abnormalities.
Dittus JL; Dudley BS; Upender M; Endress GA
Arch Pathol Lab Med; 2013 Dec; 137(12):1829-31. PubMed ID: 24283864
[TBL] [Abstract][Full Text] [Related]
28. FDA panel recommends DNA test as first line cervical cancer screening test.
McCarthy M
BMJ; 2014 Mar; 348():g2164. PubMed ID: 24637970
[No Abstract] [Full Text] [Related]
29. Assessment of new technologies for cervical cancer screening.
Villa LL
Lancet Oncol; 2008 Oct; 9(10):910-1. PubMed ID: 19071241
[No Abstract] [Full Text] [Related]
30. Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix.
Lee EJ; Mcclelland M; Wang Y; Long F; Choi SH; Lee JH
Oncol Res; 2010; 18(9):401-8. PubMed ID: 20524398
[TBL] [Abstract][Full Text] [Related]
31. Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis.
Lea JS; Coleman R; Kurien A; Schorge JO; Miller DS; Minna JD; Muller CY
Am J Obstet Gynecol; 2004 Mar; 190(3):674-9. PubMed ID: 15041998
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.
Wang SS; Smiraglia DJ; Wu YZ; Ghosh S; Rader JS; Cho KR; Bonfiglio TA; Nayar R; Plass C; Sherman ME
Cancer Res; 2008 Apr; 68(7):2489-97. PubMed ID: 18381458
[TBL] [Abstract][Full Text] [Related]
33. Control of gene expression by CpG island methylation in normal cells.
Strathdee G; Sim A; Brown R
Biochem Soc Trans; 2004 Dec; 32(Pt 6):913-5. PubMed ID: 15506922
[TBL] [Abstract][Full Text] [Related]
34. microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer.
Nahand JS; Taghizadeh-Boroujeni S; Karimzadeh M; Borran S; Pourhanifeh MH; Moghoofei M; Bokharaei-Salim F; Karampoor S; Jafari A; Asemi Z; Tbibzadeh A; Namdar A; Mirzaei H
J Cell Physiol; 2019 Aug; 234(10):17064-17099. PubMed ID: 30891784
[TBL] [Abstract][Full Text] [Related]
35. [Methylation status of the 5' CpG islands in FHIT gene in the plasma and tissues of cervical cancer patients].
Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ
Yi Chuan; 2006 Sep; 28(9):1061-6. PubMed ID: 16963412
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.
Brebi P; Hoffstetter R; Andana A; Ili CG; Saavedra K; Viscarra T; Retamal J; Sanchez R; Roa JC
Biomarkers; 2014 May; 19(3):181-8. PubMed ID: 24787227
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer.
Jo H; Kang S; Kim JW; Kang GH; Park NH; Song YS; Park SY; Kang SB; Lee HP
J Obstet Gynaecol Res; 2007 Jun; 33(3):236-41. PubMed ID: 17578348
[TBL] [Abstract][Full Text] [Related]
38. Oral cancer early detection: What will it take?
Patton LL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Apr; ():. PubMed ID: 29853267
[No Abstract] [Full Text] [Related]
39. Methylation of the RASSF1A and RARĪ² genes as a candidate biomarker for lung cancer.
Li W; Deng J; Jiang P; Zeng X; Hu S; Tang J
Exp Ther Med; 2012 Jun; 3(6):1067-1071. PubMed ID: 22970018
[TBL] [Abstract][Full Text] [Related]
40. What will it take to obtain DNA methylation markers for early cervical cancer detection?
Nephew KP
Gynecol Oncol; 2009 Feb; 112(2):291-2. PubMed ID: 19150524
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
